You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Biomaterials for mRNA based cellular reprogramming
SBC: Stem Pharm, Incorporated Topic: 100Project Summary Abstract Induced pluripotent stem cells iPSCs hold great promise in the areas of disease modeling and regenerative medicine and as a result have unique commercial potential There are currently more than ongoing clinical trials in stem cell therapies including the first in human trial using human iPSC derived retinal pigment epithelial cells to treat ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
HTS Assays for Targeting the cGAS STING Pathway in Autoimmune Diseases and Cancer
SBC: Bellbrook Labs, LLC Topic: 300SUMMARY Cytoplasmic nucleic acids alert the immune system to invading pathogens and trigger a robust type I interferon IFN response via activation of the STING stimulator of interferon genes receptor The sensor for cytoplasmic nucleic acids was recently discovered to be a cyclic GMP AMP synthase which produces a unique cyclic dinucleotide second messenger cGAMP that serves as an agonist fo ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
High Fidelity Linear MicroVector to Clone Complex Problematic and Large DNAs
SBC: VARIGEN BIOSCIENCES CORPORATION Topic: 200The goal of this research is to dramatically improve the ability to clone and analyze large and unstable DNA fragments We propose to develop a novel linear cloning vector to maximize stability of cloned DNA in the bacterial host The vector will use the replication proteins of the phage Phi to achieve the highest accuracy of replication for all DNA inserts including AT rich repetitive or str ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Automation of MicroC as a CDx for myeloma therapies
SBC: Lynx Biosciences, Inc. Topic: 102Multiple myeloma MM is a debilitating and currently incurable hematological malignancy While the median survival has increased to years MM patients ultimately relapse and become resistant to therapy Once they reach this stage it is often a trial and error process until an effective therapy can be found Furthermore the MM bone marrow tumor microenvironment plays a significant role in ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS
SBC: IFIT PROSTHETICS, LLC Topic: NABSTRACT The principal business interestiFIT Prosthetics LLCwith STTR fundingcreated a new transtibial prosthetic device and demonstrated its safetycomfortand functionIn contrast to conventionally made prosthetic limbsthe iFIT prosthesis is easily fit and aligned on the residual limb in a single sessionDue to its substantial adjustability and customized inner linerthe iFIT device is a comfortable ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Novel Continuous Esophageal Pressure Monitoring Catheter with Feeding Tube
SBC: RUSH RIVER RESEARCH CORPORATION Topic: NICHDPROJECT SUMMARY ABSTRACT Over US adults and children are on mechanical ventilators in intensive care units each year While major advancements in ventilator devices have improved outcomes for critically ill patients current ventilator practice is predominately based on measurements of airway pressure The more relevant pressure particularly to determine if mechanical ventilation is causi ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Improved preparation of cell suspensions for single cell genomics
SBC: SynderBio Inc. Topic: 172Summary Single cell sequencing SCS is a disruptive new technology that offers an unprecedented ability to interrogate the genomics DNA RNA of single cells to understand the complex biologies of normal and diseased tissues SCS is not only important for basic research but also represents a next generation of diagnostic approaches particularly for cancer While multiple SCS platforms have bee ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Improved detection of bladder cancer recurrence using a biophysical biomarker
SBC: SynderBio Inc. Topic: 102Bladder cancer is the fifth most commonly diagnosed cancer in the United StatesThree quarters of the nearlymen and women diagnosed with bladder cancer just this year will have a less aggressive form of the disease whichafter treatmentwill require frequent visits to the urologist for invasivepainful cystoscopy procedures for the remainder of their lifetimes to determine if the cancer has returnedAn ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Strategy to Identify Substances that Improve Mitochnodrial Fitness
SBC: CYTEGEN CORP Topic: NIAProject Summary Abstract Mitochondrial dysfunction causes mitochondrial diseases and is tightly linked to aging and neurodegenerative disorders such as Parkinsonandapos s and Alzheimerandapos s Recent discoveries support that mitochondrial dysfunction can be overcome to treat age related decline Cytegenandapos s hypothesis is that exercise induces the secretion of blood borne proteins that act ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Highly sensitive isothermal method and instrument for field diagnostics to facilitate malaria eradication
SBC: CASCADE BIOSYSTEMS, INC. Topic: NIAIDPlasmodium falciparum is the most virulent form of malaria causing million deaths per year Success with patient treatment and a malaria eradication campaign depends significantly on our ability to detect new infections as early as possible in the field rural areas including asymptomatic cases preferably using a small amount of blood e g from a finger prick and to clearly discrim ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health